No Detail Found!

Maternal Serum Cripto-1 Levels in Pregnancies Complicated with Placenta Previa and Placenta Accreta Spectrum (PAS)

Author(s)
Zeynep Gedik Ozkose Department of Obstetrics & Gynaecology, Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkey
Suleyman Cemil Oglak Department of Obstetrics and Gynaecology, Health Sciences University, Gazi Yasargil Training & Research Hospital,Diyarbak1r,Turkey
Mustafa Behram Department of Perinatology, Health Sciences University, Antalya Training & Research Hospital,Istanbul,Turkey
Ozge Ozdemir Department of Obstetrics & Gynaecology, Basaksehir Cam and Sakura City Hospital,Istanbul,Turkey
Zuat Acar Department of Perinatology, Health Sciences University, Sisli Hamidiye Etfal Training and Research Hospital,Istanbul,Turkey
Ismail Ozdemir Department of Obstetrics & Gynaecology, Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital,Istanbul,Turkey
Abstract
Objective: To examine maternal serum Cripto-1 levels in placenta accreta spectrum (PAS) pregnancies and compare them with placenta previa (PP) cases and healthy pregnancies. Study Design: A prospective case-control study. Place and Duration of Study: Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey, from April to September 2021. Methodology: Sixty singleton pregnant patients with PP complicated with PAS were enrolled, 45 singleton pregnant women with a diagnosis of PP without PAS, and 48 healthy uncomplicated gestational age-matched singleton pregnant women. Cripto-1 levels were determined and evaluated. Results: The median maternal serum concentrations of Cripto-1 were greater in pregnant women with PAS (3.11 ng/mL) than in the PP (2.52 ng/mL) and the control groups (2.01 ng/mL, p<0.001). Based on the Youden index, a 2.557 ng/mL cut-o value of maternal serum Cripto-1 level had a 76.7% sensitivity and 72.1% speci city to diagnose pregnancies complicated with PAS. A negative and statistically signi cant linear relationship was found between maternal serum Cripto-1 concentration and the gestational week at birth (r= -0.325, p<0.001). A positive and statistically signi cant linear relationship was found between maternal serum concentrations of Cripto-1 and maternal length of hospital stay after birth (r= 0.320, p<0.001). Conclusion: Serum Cripto-1 levels were signi cantly increased levels in pregnant women su ering from PAS than in pregnant women with PP and uncomplicated healthy pregnancies. Higher expression of Cripto-1 might be a crucial factor in the pathogenesis of PAS.
Publication Details
Page(s) 1570-1575
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 12, Year: 2022

Request the full text from PASTIC

Keywords
Placenta previa, Placenta accreta spectrum, Abnormal placental implantation, Cripto-1
0

Citations

0

Downloads

93

Views